Biotech

All Articles

F 2G rears $100M for 2nd effort to obtain new antifungal to market

.After F2G's very first attempt to acquire a brand-new training class of antifungal to market was ac...

Moderna targets $1.1 B in R&ampD investing cuts, falls 5 programs surrounded by profits stress

.Moderna has actually sworn to cut R&ampD spending by $1.1 billion through 2027. The choice to shrin...

Sanofi's $80M bet on Fulcrum dystrophy medication finishes in stage 3 go bust

.Simply 4 months after Sanofi wager $80 million in upfront cash on Pivot Therapies' losmapimod, the ...

Oncternal equity sinks 60% in the middle of discharges, trial discontinuations

.Cancer cells company Oncternal Therapies is actually folding all its scientific tests and giving up...

Roche is keeping out chances that its injectable excessive weight prospect could at some point display 25% weight-loss in late-stage trial

.Roche is keeping out chances that its own injectable obesity prospect might ultimately demonstrate ...

Novo Nordisk barrages 'remarkable' fat burning result for dual-acting dental medicine in very early test

.Novo Nordisk has actually elevated the cover on a phase 1 test of its oral amylin and also GLP-1 re...

AbbVie takes legal action against BeiGene over blood stream cancer cells medicine trade secrets

.Only a couple of short weeks after gaining an FDA Fast Track tag for its investigational BTK degrad...

Lilly provides one-two hit with 2nd tranche of positive information on weekly insulin prospect

.Shortly after a good information decline for Eli Lilly's efsitora alfa, the Indianapolis-based comp...

BridgeBio cuts gene therapy budget as scientific records let down

.BridgeBio Pharma is actually slashing its own genetics therapy finances and also drawing back from ...

GSK surrenders HSV injection really hopes after period 2 fail, resigning race to Moderna, BioNTech

.GSK's try to establish the very first vaccination for herpes simplex virus (HSV) has actually finis...